Literature DB >> 24664352

The neurobiology of cancer pain.

Brian L Schmidt1.   

Abstract

The global burden of cancer pain is enormous and opioids, despite their side effects, remain the primary therapeutic approach. The cause of cancer pain is unknown. Mechanisms driving cancer pain differ from those mechanisms responsible for inflammatory and neuropathic pain. The prevailing hypothesis put forward to explain cancer pain posits that cancers generate and secrete mediators which sensitize and activate primary afferent nociceptors in the cancer microenvironment. Moreover, cancers induce neurochemical reorganization of the spinal cord, which contributes to spontaneous activity and enhanced responsiveness. The purpose of this review, which covers clinical and preclinical studies, is to highlight those peripheral and central mechanisms responsible for cancer pain. The challenges facing neuroscientists and clinicians studying and ultimately treating cancer pain are discussed.
© The Author(s) 2014.

Entities:  

Keywords:  cancer; cancer pain; pain; sensory system; tumor

Mesh:

Year:  2014        PMID: 24664352      PMCID: PMC4161642          DOI: 10.1177/1073858414525828

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  120 in total

1.  CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.

Authors:  Iryna A Khasabova; James Gielissen; Anisha Chandiramani; Catherine Harding-Rose; Desiree Abu Odeh; Donald A Simone; Virginia S Seybold
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.

Authors:  Bing-xu Ren; Xiao-ping Gu; Ya-guo Zheng; Cheng-long Liu; Dan Wang; Yu-e Sun; Zheng-liang Ma
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

3.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

Review 4.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

5.  Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.

Authors:  Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

6.  Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Authors:  Mary Ann C Sabino; Joseph R Ghilardi; Joost L M Jongen; Cathy P Keyser; Nancy M Luger; David B Mach; Christopher M Peters; Scott D Rogers; Matthew J Schwei; Carmen de Felipe; Patrick W Mantyh
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

7.  The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.

Authors:  XiaoPing Gu; Juan Zhang; ZhengLiang Ma; JunHua Wang; XiaoFang Zhou; YanQing Jin; XiaoPing Xia; Qin Gao; FengMei Mei
Journal:  Eur J Pain       Date:  2009-10-07       Impact factor: 3.931

8.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.

Authors:  Laszlo Karai; Dorothy C Brown; Andrew J Mannes; Stephen T Connelly; Jacob Brown; Michael Gandal; Ofer M Wellisch; John K Neubert; Zoltan Olah; Michael J Iadarola
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.

Authors:  Tamara E King; Sangita C Pawar; Lisa Majuta; Isis C Sroka; Danyel Wynn; Manolis C Demetriou; Raymond B Nagle; Frank Porreca; Anne E Cress
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

10.  Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors.

Authors:  Kiran Kumar Bali; Varun Venkataramani; Venkata P Satagopam; Pooja Gupta; Reinhard Schneider; Rohini Kuner
Journal:  Mol Pain       Date:  2013-09-25       Impact factor: 3.395

View more
  27 in total

1.  Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates.

Authors:  Zilong Wang; Changyu Jiang; Qianru He; Megumi Matsuda; Qingjian Han; Kaiyuan Wang; Sangsu Bang; Huiping Ding; Mei-Chuan Ko; Ru-Rong Ji
Journal:  Sci Transl Med       Date:  2020-02-19       Impact factor: 17.956

2.  A checkpoint to pain.

Authors:  Michael Hirth; Jagadeesh Gandla; Rohini Kuner
Journal:  Nat Neurosci       Date:  2017-06-27       Impact factor: 24.884

3.  PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.

Authors:  Gang Chen; Yong Ho Kim; Hui Li; Hao Luo; Da-Lu Liu; Zhi-Jun Zhang; Mark Lay; Wonseok Chang; Yu-Qiu Zhang; Ru-Rong Ji
Journal:  Nat Neurosci       Date:  2017-05-22       Impact factor: 24.884

Review 4.  The Role of Schwann Cells in Cancer.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Adv Biol (Weinh)       Date:  2022-06-04

Review 5.  What pain tells us about cancer.

Authors:  Brian L Schmidt
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

Review 6.  Acute and Chronic Pain from Facial Skin and Oral Mucosa: Unique Neurobiology and Challenging Treatment.

Authors:  Man-Kyo Chung; Sheng Wang; Se-Lim Oh; Yu Shin Kim
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 7.  Glia and Orofacial Pain: Progress and Future Directions.

Authors:  Yi Ye; Elizabeth Salvo; Marcela Romero-Reyes; Simon Akerman; Emi Shimizu; Yoshifumi Kobayashi; Benoit Michot; Jennifer Gibbs
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

8.  Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.

Authors:  Jean-Marc G Guedon; Geraldine Longo; Lisa A Majuta; Michelle L Thomspon; Michelle N Fealk; Patrick W Mantyh
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

Review 9.  Neuroimmunology of cancer and associated symptomology.

Authors:  Nicole N Scheff; Jami L Saloman
Journal:  Immunol Cell Biol       Date:  2021-09-12       Impact factor: 5.853

10.  Seeding of breast cancer cell line (MDA-MB-231LUC+) to the mandible induces overexpression of substance P and CGRP throughout the trigeminal ganglion and widespread peripheral sensory neuropathy throughout all three of its divisions.

Authors:  Silvia Gutierrez; James C Eisenach; M Danilo Boada
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.